SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 137 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,735,563 | +119.1% | 68,195 | +106.8% | 0.65% | +162.8% |
| Q3 2022 | $792,000 | -47.3% | 32,969 | -57.8% | 0.25% | -41.3% |
| Q2 2022 | $1,504,000 | +83.2% | 78,182 | +65.5% | 0.42% | -27.2% |
| Q1 2022 | $821,000 | -58.8% | 47,253 | -48.0% | 0.58% | +57.5% |
| Q4 2021 | $1,991,000 | +12.8% | 90,934 | -1.6% | 0.37% | -22.7% |
| Q3 2021 | $1,765,000 | +736.5% | 92,385 | +874.7% | 0.48% | +550.7% |
| Q4 2020 | $211,000 | – | 9,478 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |